• Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD.

  • Nov 1 2023
  • Length: 1 hr and 24 mins
  • Podcast
Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD. cover art

Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD.

Listen for free

View show details

  • Summary

  • "I don't know how I'm going to live with myself if I don't stay true to what I believe." We evaluate the recent published work describing apabetalone, a small molecule drug from Resverlogix Corp that has been around for awhile and in clinic for other indications and is now being assessed more seriously as a potential therapeutic for FSHD. Overall, while lacking in some areas, this initial study is generally positive and supports that it is a new candidate worthy of further evaluation.

    --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message
    Show more Show less
Show more Show less

What listeners say about Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD.

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.ca reviews

Amazon Reviews
No reviews are available